Nephros, Inc.
NASDAQNephros already dropped its Q1 2026 numbers after the close on May 7. Revenue came in at $5.21M, beating the $5.02M estimate. EPS landed at $0.01, in line with expectations. The question heading into today's session is whether that mild beat is enough to reverse a stock that is still nursing deep wounds from its last report. The most important context for this print is what…
Snapshot as of 23 Jun 2026
Nephros already dropped its Q1 2026 numbers after the close on May 7. Revenue came in at $5.21M, beating the $5.02M estimate. EPS landed at $0.01, in line with expectations. The question heading into today's session is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NEPH — free to start on ORTEX.
Sign up for free →Open NEPH on ORTEX